We've moved from Tuesday to Wednesday

No, we're not a day late. In case you missed last week's note, your FierceBiotechResearch publication now arrives in your inboxes on Wednesdays rather than Tuesdays. The Fierce life sciences family of publications is growing, and we needed to streamline our weekly publishing schedule. As always, thanks for reading, and see you back here next Wednesday. -- John Carroll

Suggested Articles

UPenn scientists found blocking the Wnt/beta-catenin pathway in endothelial cells made chemotherapy more effective in mouse models of glioblastoma.

Astellas’ Xospata and Novartis’ Rydapt may help treat lung cancer that has grown resistant to EGFR inhibitors, researchers discovered.

Dutch scientists used stem cells from CF patients to demonstrate a technique that corrects a mutation in the gene CFTR without having to cut DNA.